Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
1 Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva Switzerland.
2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, the Netherlands.
3 Pandemic Sciences Institute, University of Oxford, Oxford, UK.
4 Heidelberg Institute of Global Health (HIGH), Heidelberg University Hospital, Heidelberg, Germany.
5 Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
6 Institute for Infection and Immunity, St George's, University of London, London, UK; Infection Prevention and Control, Universitäts-Kinderspital Beider Basel, Basel, Switzerland.
7 Nuffield Department of Primary Care Health Sciences, Oxford University.
8 Medical-Surgical Intensive Care Unit and Inserm CIC 1435 & UMR 1092, CHU Limoges, Limoges, France.
9 Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Pandemic and Disaster Preparedness Research Centre, Rotterdam, the Netherlands.
10 Infectious Diseases and Microbiology, Hospital Universitario Virgen Macarena, Department of Medicine, University of Sevilla, Biomedicine Institute of Sevilla (IBiS), CSIC, Sevilla, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
11 Department of Infectious Diseases, University of Verona, Verona, Italy.
12 Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
13 Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva Switzerland. Electronic address: marlieke.dekraker@hcuge.ch.